Lista de obras - Angela Buonadonna - Dominio Público Uruguay

A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity

artículo científico publicado en 2020

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

artículo científico publicado en 2014

Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients

artículo científico publicado en 1995

Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuclear cells is a predictive marker of the irinotecan to SN38 activation step in colorectal cancer patients.

artículo científico publicado en 2005

Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines

artículo científico publicado en 2015

Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma

artículo científico publicado en 2016

Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer

artículo científico publicado en 1999

Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk

artículo científico publicado en 2014

Exocrine and Endocrine Modulation in Common Gastric Carcinoma

artículo científico publicado en 2012

FOLFOX2 regimen in the treatment of advanced colorectal cancer: a comparison between elderly and young patients

artículo científico publicado en 2006

FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials.

artículo científico publicado en 2016

Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.

artículo científico publicado en 2014

Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer

artículo científico publicado en 2009

HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.

artículo científico publicado en 2015

Ifosfamide in the adjuvant therapy of soft tissue sarcomas.

artículo científico publicado en 2003

Improved outcome with multimodal treatment and imatinib rechallenge in advanced GIST

artículo científico publicado en 2014

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

artículo científico publicado en 2014

Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies ⬇️

artículo científico publicado en 2011

Malignant cardiac tumors: diagnosis and treatment.

artículo científico

Morphologic shift associated with aberrant cytokeratin expression in a GIST patient after tyrosine kinase inhibitors therapy. A case report with a brief review of the literature.

artículo científico publicado en 2015

Neoplastic pericardial disease in lung cancer: Impact on outcomes of different treatment strategies. A multicenter study

artículo científico publicado en 2010

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

artículo científico publicado en 2014

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial.

artículo científico publicado en 2010

Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.

artículo científico publicado en 2013

Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients

artículo científico publicado en 2012

Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients

artículo científico publicado en 2016

Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.

artículo científico publicado en 2009

Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group.

artículo científico publicado en 2013

Prognostic factors in soft tissue sarcomas: a study of 395 patients

artículo científico publicado en 2002

Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review).

artículo científico publicado en 2010

Solid pseudopapillary tumour of the pancreas

artículo científico publicado en 2003

Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role

artículo científico publicado en 2003

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

artículo científico publicado en 2006

[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy].

artículo científico publicado en 2015

Lista de obras de Angela Buonadonna

A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients

Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuclear cells is a predictive marker of the irinotecan to SN38 activation step in colorectal cancer patients.

Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines

Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma

Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer

Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk

Exocrine and Endocrine Modulation in Common Gastric Carcinoma

FOLFOX2 regimen in the treatment of advanced colorectal cancer: a comparison between elderly and young patients

FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials.

Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.

Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer

HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.

Ifosfamide in the adjuvant therapy of soft tissue sarcomas.

Improved outcome with multimodal treatment and imatinib rechallenge in advanced GIST

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies ⬇️

Malignant cardiac tumors: diagnosis and treatment.

Morphologic shift associated with aberrant cytokeratin expression in a GIST patient after tyrosine kinase inhibitors therapy. A case report with a brief review of the literature.

Neoplastic pericardial disease in lung cancer: Impact on outcomes of different treatment strategies. A multicenter study

Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancer.

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial.

Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.

Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients

Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients

Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.

Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group.

Prognostic factors in soft tissue sarcomas: a study of 395 patients

Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review).

Solid pseudopapillary tumour of the pancreas

Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy].